Vanda Moves Drug For GLP-1 Nausea And Vomiting Into Phase III

 
• By Alaric DeArment
  
Novo Nordisk And India's Emcure Have Struck A Deal For GLP-1 Semaglutide Wegovy
Vanda announced positive results for tradipitant in patients taking Novo Nordisk's Wegovy. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapy Areas